Ionis Pharmaceuticals, Inc.
SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF
Last updated:
Abstract:
The present disclosure provides oligomeric compounds. Certain such oligomeric compounds are useful for hybridizing to a complementary nucleic acid, including but not limited, to nucleic acids in a cell. In certain embodiments, hybridization results in modulation of the amount activity or expression of the target nucleic acid in a cell. In certain embodiments, certain oligomeric compounds selectively reduce the expression of a target nucleic acid transcript relative to a non-target nucleic acid transcript.
Status:
Application
Type:
Utility
Filling date:
29 Mar 2019
Issue date:
20 Feb 2020